Significados de nervous system diseases en inglés

Therefore, liproxstatin-1 may be a promising drug for the treatment of central nervous system diseases.

Ciliary neurotrophic growth factor is considered a potential therapeutic agent for central nervous system diseases.

Protein therapeutics targeting the ventricular system may provide new approaches in treating central nervous system diseases.

The ion channels discussed here are targets for multiple nervous system diseases, including epilepsy and neuropathic pain.

Neuroinflammation and cell death are among the common symptoms of many central nervous system diseases and injuries.

These results suggest that a7 nAChR PAMs have therapeutic potential in central nervous system diseases with cognitive impairments.

The drug has shown promise in pre-clinical models for pain and other central and peripheral nervous system diseases, NeuroSearch said.

Carmel is an Atlanta, Georgia-based company that develops prescription drugs and nutraceuticals for cardiovascular, metabolic, and central nervous system diseases.

Background and purpose: Intravascular transplantation of neural stem cells represents a minimally invasive therapeutic approach for the treatment of central nervous system diseases.

The Company mainly provides its products in the treatment of tumor immunotherapy, metabolic diseases, inflammation or autoimmune diseases, as well as nervous system diseases.

This finding could have significant implications in advancing minimally invasive intravascular therapeutics for regenerative medicine or cell-based drug delivery systems for central nervous system diseases.

Methods: One hundred subjects (20 normal volunteers and 80 volunteers with various central nervous system diseases) participated in the study.